Recent Blog Articles
Taking up adaptive sports
Cutting and self-harm: Why it happens and what to do
Discrimination at work is linked to high blood pressure
Pouring from an empty cup? Three ways to refill emotionally
Give praise to the elbow: A bending, twisting marvel
Sneezy and dopey? Seasonal allergies and your brain
The FDA relaxes restrictions on blood donation
Apps to accelerometers: Can technology improve mental health in older adults?
Swimming and skin: What to know if a child has eczema
A muscle-building obsession in boys: What to know and do
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Charlie Schmidt
An emerging treatment option for men with recurring prostate cancer after radiation therapy
Charlie Schmidt
Improving PET scans are good news for doctors and patients alike
Charlie Schmidt
Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures
Charlie Schmidt
New high-resolution imaging scans approved for use in prostate cancer
Charlie Schmidt
The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer
Charlie Schmidt
New online model identifies which men can have fewer biopsies on active surveillance
Charlie Schmidt
Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Charlie Schmidt
Hormonal treatments for prostate cancer are often given late
Charlie Schmidt
A new hormonal therapy for prostate cancer is under expedited FDA review
Charlie Schmidt
New drugs approved for advanced BRCA-positive prostate cancer
Charlie Schmidt
Combining different biopsies limits uncertainty in prostate cancer diagnosis
Charlie Schmidt
New radiation therapies keep advanced prostate cancer in check
Charlie Schmidt
New study compares long-term side effects from different prostate cancer treatments
Charlie Schmidt
African American and white men who receive comparable treatments for prostate cancer have similar survival
Charlie Schmidt
Researchers urge prostate cancer screening for men with BRCA gene defects
Charlie Schmidt
Most men can hold off on radiation after prostate cancer surgery
Charlie Schmidt
Darolutamide approved for nonmetastatic castration-resistant prostate cancer
Men's Health
Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer
Charlie Schmidt
Popular drugs used for treating enlarged prostates associated with high-grade prostate cancer
Charlie Schmidt
From Brexit to TRexit: Transperineal biopsies pose a challenge to the traditional transrectal biopsy method
Charlie Schmidt
Can a man with abnormal PSA and a negative diagnostic MRI avoid a prostate biopsy? It’s debatable
Charlie Schmidt
Highly accurate test reveals recurring prostate cancer
Men's Health
African American men respond better to treatments for advanced prostate cancer in clinical trials
Charlie Schmidt
